ES2782380T5 - Método de especificación y cultivo de linaje del músculo esquelético escalable - Google Patents

Método de especificación y cultivo de linaje del músculo esquelético escalable Download PDF

Info

Publication number
ES2782380T5
ES2782380T5 ES14858383T ES14858383T ES2782380T5 ES 2782380 T5 ES2782380 T5 ES 2782380T5 ES 14858383 T ES14858383 T ES 14858383T ES 14858383 T ES14858383 T ES 14858383T ES 2782380 T5 ES2782380 T5 ES 2782380T5
Authority
ES
Spain
Prior art keywords
cell line
myogenic
self
differentiation
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14858383T
Other languages
English (en)
Spanish (es)
Other versions
ES2782380T3 (es
Inventor
Nicholas Genovese
R Roberts
Bhanu Telugu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The Upside Foods Inc
University of Missouri-Columbia
University of Missouri–St. Louis
Original Assignee
The Upside Foods Inc
University of Missouri-Columbia
University of Missouri–St. Louis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53005145&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2782380(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Upside Foods Inc, University of Missouri-Columbia, University of Missouri–St. Louis filed Critical The Upside Foods Inc
Application granted granted Critical
Publication of ES2782380T3 publication Critical patent/ES2782380T3/es
Publication of ES2782380T5 publication Critical patent/ES2782380T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/602—Sox-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/603—Oct-3/4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/604—Klf-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES14858383T 2013-10-30 2014-10-30 Método de especificación y cultivo de linaje del músculo esquelético escalable Active ES2782380T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361962068P 2013-10-30 2013-10-30
PCT/US2014/063250 WO2015066377A1 (en) 2013-10-30 2014-10-30 Method for scalable skeletal muscle lineage specification and cultivation

Publications (2)

Publication Number Publication Date
ES2782380T3 ES2782380T3 (es) 2020-09-14
ES2782380T5 true ES2782380T5 (es) 2023-05-08

Family

ID=53005145

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14858383T Active ES2782380T5 (es) 2013-10-30 2014-10-30 Método de especificación y cultivo de linaje del músculo esquelético escalable

Country Status (10)

Country Link
US (3) US20160251625A1 (enExample)
EP (1) EP3071040B2 (enExample)
JP (2) JP6728049B2 (enExample)
CN (2) CN111154726A (enExample)
AU (2) AU2014342180B2 (enExample)
BR (1) BR112016009803B1 (enExample)
CA (1) CA2928726A1 (enExample)
ES (1) ES2782380T5 (enExample)
IL (2) IL296889A (enExample)
WO (1) WO2015066377A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160251625A1 (en) 2013-10-30 2016-09-01 The Curators Of The University Of Missouri Method for scalable skeletal muscle lineage specification and cultivation
WO2017100498A1 (en) 2015-12-11 2017-06-15 The Johns Hopkins University Isolation of fusion-competent myoblasts and therapeutic applications thereof related to muscular dystrophy
MX2018008733A (es) * 2016-01-14 2019-01-28 Memphis Meats Inc Metodos para extender la capacidad replicativa de las celulas somaticas durante un proceso de cultivo ex vivo.
IL320653A (en) 2016-07-11 2025-07-01 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Systems and methods for growing cells in vitro
ES2985769T3 (es) 2017-05-06 2024-11-07 Upside Foods Inc Composiciones y métodos para aumentar la densidad de cultivo de una biomasa celular dentro de una infraestructura de cultivo
US20200140821A1 (en) * 2017-06-07 2020-05-07 Wild Type, Inc. Ex vivo meat production
US11479792B2 (en) 2017-07-13 2022-10-25 Upside Foods, Inc. Compositions and methods for increasing the efficiency of cell cultures used for food production
KR20200071061A (ko) 2017-07-15 2020-06-18 알레프 팜스 리미티드 배양된 육류 조성물
GB2573327B (en) * 2018-05-03 2021-05-12 Mosa Meat Bv Apparatus and process for production of tissue from cells
US12478571B2 (en) 2018-12-17 2025-11-25 Pontis Biologics, Inc. Enzyme based compositions and methods for removing dental calculi
EP3969571A4 (en) 2019-05-14 2023-05-24 Aleph Farms Ltd. PLURIPOTENTE CELL AGGREGATES AND THEIR USE
IL288338B2 (en) 2019-05-28 2023-02-01 Upside Foods Inc Apparatuses and methods for preparing a comestible meat product
MX2022006095A (es) 2019-11-20 2022-08-16 Upside Foods Inc Aparatos y sistemas para preparar un producto carnico.
PH12022551329A1 (en) * 2019-12-02 2024-06-24 Avant Meats Company Ltd Methods of meat production by in vitro cell cultivation
US20210235733A1 (en) 2020-02-04 2021-08-05 Memphis Meats, Inc. Characteristics of meat products
CN115989318A (zh) 2020-06-05 2023-04-18 阿普賽德食品公司 用于产生免屠宰肉的营养培养基
GB202008821D0 (en) * 2020-06-10 2020-07-22 Highersteaks Ltd Systems and methods for cell conversion
US12252681B2 (en) 2020-08-18 2025-03-18 Upside Foods, Inc. Systems, devices, and methods for sterilizing bioreactors and culture media
US20220195368A1 (en) * 2020-12-21 2022-06-23 Upside Foods, Inc. Fluid conduit with radial expansion of fluid flow
US11912967B2 (en) 2020-12-22 2024-02-27 Upside Foods, Inc. Systems and methods for cultivating tissue on porous substrates
WO2022156939A1 (en) * 2021-01-22 2022-07-28 HigherSteaks Limited Products for cell conversion
US20240352423A1 (en) 2021-03-10 2024-10-24 Terasaki Institute For Biomedical Innovation Methods and systems of producing products such as animal derived products
AU2022254053A1 (en) 2021-04-07 2023-10-12 The Upside Group Inc. Generation of cell-based products for consumption that comprise proteins derived from exotic, endangered, and extinct species
WO2022232322A1 (en) 2021-04-28 2022-11-03 Upside Foods, Inc. Generation of cell-based products for human consumption
WO2022234586A1 (en) 2021-05-06 2022-11-10 Yeda Research And Development Co. Ltd. Method for inducing hypertrophic muscle fibers for industrial meat production
BR112023024911A2 (pt) * 2021-05-28 2024-02-20 Abs Global Inc Sistemas e métodos de reprodução in vitro em pecuária
US20220400716A1 (en) 2021-06-11 2022-12-22 Upside Foods, Inc. Comestible cell-based meat products comprising dry cell powder and methods of making such products
WO2022265632A1 (en) 2021-06-16 2022-12-22 Upside Foods, Inc. Plant fat-based scaffolds for the growth of cell-based meats and methods of making such products
US20240327794A1 (en) 2021-07-09 2024-10-03 Suprême Foodstuffs comprising cells differentiated from engineered oligopotent stem cells
EP4418874A4 (en) 2021-10-19 2025-09-24 Eat Scifi Inc PLANT/ANIMAL CELL BASED HYBRID MEAT SUBSTITUTE
WO2023122688A1 (en) * 2021-12-23 2023-06-29 Upside Foods, Inc. Scaling up myogenic tissue: late passage myogenicity
WO2023240152A1 (en) 2022-06-07 2023-12-14 Upside Foods, Inc. Engineering cell lines capable of proliferation in growth factor free media formulations
EP4292440A1 (en) 2022-06-14 2023-12-20 Upside Foods, Inc. Suspension based chicken product formulation
EP4293109A1 (en) 2022-06-14 2023-12-20 Upside Foods, Inc. Non-skeletal muscle-derived cells as a source of suspension capable myogenic cells for cultured foods
US11981884B2 (en) 2022-10-17 2024-05-14 Upside Foods, Inc. Pipe-based bioreactors for producing comestible meat products and methods of using the same
US12653214B2 (en) 2023-01-06 2026-06-16 Upside Foods, Inc. Compositions and methods of making comestible cell-based meat fillets
WO2024218715A1 (en) 2023-04-19 2024-10-24 Btl Healthcare Technologies A.S. Culture media based on protein hydrolysate and a process for preparing thereof
CN121464211A (zh) * 2023-07-10 2026-02-03 中国农业大学 一种猪多能干细胞的肌源性分化方法及其用于细胞培养肉制备
EP4497814A1 (de) 2023-07-28 2025-01-29 Green Elephant Biotech GmbH Vorrichtung zur vermehrung von differenzierten und undifferenzierten zellen und verwendung der vorrichtung für die herstellung von kultivierten lebensmitteln
IL325324A (en) 2023-09-01 2026-02-01 Upside Foods Inc Transposon system and methods of using it
US20250120418A1 (en) * 2023-10-12 2025-04-17 Btl Healthcare Technologies A.S. Pet food, methods and devices for producing pet food
US12668774B2 (en) 2023-10-12 2026-06-30 Btl Healthcare Technologies A.S. Product, system and method of cell cultivation
WO2025141211A1 (en) * 2023-12-29 2025-07-03 Meatable B.V. Cells for forward programming

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510254A (en) 1986-04-18 1996-04-23 Advanced Tissue Sciences, Inc. Three dimensional cell and tissue culture system
IE904639A1 (en) * 1989-12-21 1991-07-17 Univ Georgia Bovine myogenic factor gene
US5298422A (en) * 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
WO1999031222A1 (en) 1997-12-18 1999-06-24 Willem Frederik Van Eelen Industrial scale production of meat from in vitro cell cultures
WO1999043786A2 (en) 1998-02-27 1999-09-02 Purdue Research Foundation Submucosa gel compositions
US6537782B1 (en) 1998-06-01 2003-03-25 Chugai Seiyaku Kabushiki Kaisha Media for culturing animal cells and process for producing protein by using the same
US6835390B1 (en) 2000-11-17 2004-12-28 Jon Vein Method for producing tissue engineered meat for consumption
AU2004249812B8 (en) * 2003-06-25 2011-09-15 Ottawa Hospital Research Institute Methods and compositions for modulating stem cell growth and differentiation
DE102004017484B4 (de) 2004-04-08 2006-07-06 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung einer biologischen Materialzusammensetzung tierischen Ursprungs
US20060121006A1 (en) 2004-09-10 2006-06-08 Chancellor Michael B Production of nutritional and therapeutic products from cultured animal cells
PL1789063T3 (pl) 2004-09-17 2012-05-31 Hampton Creek Inc Mięso do spożycia hodowane techniką inżynierii tkankowej i sposób wytwarzania mięsa do spożycia hodowanego techniką inżynierii tkankowej
EP1956923A1 (en) * 2005-11-02 2008-08-20 Nestec S.A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
CA2644046A1 (en) * 2006-02-28 2007-09-07 Trustees Of Boston University Metabolic regulators and uses thereof
DE102007029699B4 (de) 2007-06-27 2010-12-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Isolierte proliferierende Zellen mit Stammzelleigenschaften aus adultem Gewebe von wechselwarmen Wirbeltieren, stabile Zellkulturen davon und Verfahren zu deren Herstellung
CN101624570B (zh) 2008-07-07 2011-04-13 刘志军 中药培养养殖肉灵芝方法及养殖肉灵芝保健品的制备方法
US20110301249A1 (en) 2008-12-12 2011-12-08 Kedar Challakere Stem cell enhanced protein products and uses therof
US20110091604A1 (en) 2009-10-21 2011-04-21 Seth Adrian Miller Synthetic meat
US8883502B2 (en) 2010-09-09 2014-11-11 The Regents Of The University Of California Expandable cell source of neuronal stem cell populations and methods for obtaining and using them
WO2012170995A2 (en) * 2011-06-10 2012-12-13 University Of Georgia Research Foundation, Inc. Avian induced pluripotent stem cells and their use
CA2780087A1 (en) 2011-06-14 2012-12-14 Jacques P. Tremblay Myogenic differentiation of stem cells and uses thereof
US8883503B2 (en) 2011-06-23 2014-11-11 Indian Institute Of Technology Kanpur Hydrogel scaffolds for tissue engineering
KR20210095240A (ko) 2011-07-12 2021-07-30 임파서블 푸즈 인크. 소비재를 위한 방법 및 조성물
US10039306B2 (en) 2012-03-16 2018-08-07 Impossible Foods Inc. Methods and compositions for consumables
CN103747693B (zh) 2011-07-26 2017-08-01 密苏里大学董事会 可食用工程肉
CA2792081C (en) * 2011-10-11 2020-10-27 Bond University Ltd Layered compositions comprising 3d nanofibre webbing for tissue repair
US9862929B2 (en) * 2011-11-18 2018-01-09 Kyoto University Method of inducing differentiation from pluripotent stem cells to skeletal muscle cells
EP2825694A4 (en) 2012-03-16 2016-04-20 Impossible Foods Inc AFFINITY REAGENTS FOR PROTEIN CLEANING
EP2831291B1 (en) 2012-03-28 2019-04-24 Modern Meadow, Inc. Engineered leather and methods of manufacture thereof
AU2014205122B2 (en) 2013-01-11 2017-11-02 Impossible Foods Inc. Non-dairy cheese replica comprising a coacervate
US10525075B2 (en) 2013-02-22 2020-01-07 The Board Of Trustees Of The Leland Stanford Junior University Compounds, compositions, methods, and kits relating to telomere extension
WO2015038988A1 (en) 2013-09-13 2015-03-19 Modern Meadow, Inc. Edible and animal-product-free microcarriers for engineered meat
US20160251625A1 (en) 2013-10-30 2016-09-01 The Curators Of The University Of Missouri Method for scalable skeletal muscle lineage specification and cultivation
US20150296834A1 (en) 2014-04-17 2015-10-22 Savage River, Inc. dba Beyond Meat, Inc. Plant based meat structured protein products
US9526267B2 (en) 2014-04-17 2016-12-27 Savage River, Inc. Nutrient-dense meat structured protein products
WO2017019125A1 (en) 2015-07-24 2017-02-02 Synthetic Genomics, Inc. A protein rich food ingredient from biomass and methods of production
MX2018008733A (es) 2016-01-14 2019-01-28 Memphis Meats Inc Metodos para extender la capacidad replicativa de las celulas somaticas durante un proceso de cultivo ex vivo.
ES2985769T3 (es) 2017-05-06 2024-11-07 Upside Foods Inc Composiciones y métodos para aumentar la densidad de cultivo de una biomasa celular dentro de una infraestructura de cultivo
US11479792B2 (en) 2017-07-13 2022-10-25 Upside Foods, Inc. Compositions and methods for increasing the efficiency of cell cultures used for food production

Also Published As

Publication number Publication date
US20210171912A1 (en) 2021-06-10
US10920196B2 (en) 2021-02-16
AU2014342180B2 (en) 2019-01-03
BR112016009803A8 (pt) 2018-01-30
US20160227830A1 (en) 2016-08-11
EP3071040B1 (en) 2020-01-01
JP2016535601A (ja) 2016-11-17
CN111154726A (zh) 2020-05-15
US20160251625A1 (en) 2016-09-01
IL296889A (en) 2022-12-01
BR112016009803B1 (pt) 2022-02-08
EP3071040B2 (en) 2022-12-28
AU2019202244A1 (en) 2019-04-18
IL245292B (en) 2022-10-01
WO2015066377A1 (en) 2015-05-07
IL245292A0 (en) 2016-06-30
CN105899079A (zh) 2016-08-24
ES2782380T3 (es) 2020-09-14
JP6728049B2 (ja) 2020-07-22
EP3071040A1 (en) 2016-09-28
BR112016009803A2 (pt) 2017-12-05
IL245292B2 (en) 2023-02-01
JP2020089381A (ja) 2020-06-11
CA2928726A1 (en) 2015-05-07
EP3071040A4 (en) 2017-06-21
AU2019202244B2 (en) 2021-09-23
AU2014342180A1 (en) 2016-05-19

Similar Documents

Publication Publication Date Title
ES2782380T3 (es) Método de especificación y cultivo de linaje del músculo esquelético escalable
JP6131433B2 (ja) 細胞ｒｎａ発現のための方法
ES2589122T3 (es) Estimulación de la ruta de la Wnt en la reprogramación de células somáticas
US20110014164A1 (en) Efficient induction of pluripotent stem cells using small molecule compounds
CA3181811A1 (en) Systems and methods for cell conversion
Mo et al. Generation and characterization of bat-induced pluripotent stem cells
Yakhkeshi et al. In vitro improvement of quail primordial germ cell expansion through activation of TGF‐beta signaling pathway
CN105764334B (zh) 加强肿瘤生长的方法
US20210395692A1 (en) Method For Reducing Differentiation Resistance Of Pluripotent Stem Cells
EP2734617B1 (en) Use of cellular extracts for obtaining pluripotent stem cells
Lluis et al. Resetting epigenetic signatures to induce somatic cell reprogramming
Siddall et al. Myc-what we have learned from flies
HK1229164B (en) Method for scalable skeletal muscle lineage specification and cultivation
HK1229164A1 (en) Method for scalable skeletal muscle lineage specification and cultivation
Almeida An investigation of cell cycle regulation during in vitro models of diapause
EP2646557B1 (en) Method for cellular rna expression
Alonso Human Pluripotent Stem Cells and CRISPR-Cas9 Genome Editing to Model Diabetes
FATHIMA ISOLATION AND CHARACTERIZATION OF MYOSATELLITE CELLS FROM CLARIAS MAGUR (HAMILTON, 1822)
Francis Induced pluripotent stem cells as an alternative to embryonic stem cells for the treatment of type 1 diabetes